Matches in SemOpenAlex for { <https://semopenalex.org/work/W4295428999> ?p ?o ?g. }
Showing items 1 to 97 of
97
with 100 items per page.
- W4295428999 abstract "Worldwide, metabolic dysfunction-associated fatty liver disease (MAFLD) is the most common chronic liver disease. MAFLD is associated with insulin resistance, type 2 diabetes mellitus (T2DM), obesity, hypertension, and dyslipidemia. Early diagnosis and management are vital to improving hepatic and cardiometabolic outcomes. Dietary change, weight loss, and structured exercise are the main treatment approaches for fatty liver disease. Since 2010, several investigational drug treatments failed to achieve regulatory approval due to mixed and unsatisfactory results. Although glucagon-like peptide 1 receptor agonists (GLP1-RAs) showed initial promise as therapeutic agents, metabolic liver damage can recur after monotherapy cessation. Dual incretin receptor agonists target the receptors for glucagon-like peptide 1 (GLP-1) and gastric inhibitory peptide (GIP). Importantly, on May 13, 2022, the US Food and Drug Administration (FDA) approved tirzepatide as the first dual GLP-1 and GIP receptor agonist for the treatment of T2DM. Dual incretin receptor agonists induce weight loss and enhance hepatic lipid metabolism and systemic insulin sensitivity. Insulin resistance and hepatic steatosis are the main contributors to the development of MAFLD. Treatment with dual incretin analogs reduces hepatic steatosis, lobular inflammation, liver cell damage, fibrosis, and total liver triglyceride levels. The availability of dual incretin receptor agonists for patients with MAFLD may result in weight control, normalizing insulin sensitivity, and reducing or even reversing metabolic dysfunction and liver damage. This Editorial aims to provide an update and discuss how treatment with dual incretin receptor agonists may maintain normal glucose levels and weight and control MAFLD." @default.
- W4295428999 created "2022-09-14" @default.
- W4295428999 creator A5029492576 @default.
- W4295428999 creator A5032639696 @default.
- W4295428999 creator A5037581187 @default.
- W4295428999 creator A5087011184 @default.
- W4295428999 date "2022-09-12" @default.
- W4295428999 modified "2023-10-18" @default.
- W4295428999 title "Editorial: Treatment with Dual Incretin Receptor Agonists to Maintain Normal Glucose Levels May Also Maintain Normal Weight and Control Metabolic Dysfunction-Associated Fatty Liver Disease (MAFLD)" @default.
- W4295428999 cites W2062812115 @default.
- W4295428999 cites W2215535790 @default.
- W4295428999 cites W2895666357 @default.
- W4295428999 cites W2969584990 @default.
- W4295428999 cites W3011482816 @default.
- W4295428999 cites W3014551320 @default.
- W4295428999 cites W3015345942 @default.
- W4295428999 cites W3091471007 @default.
- W4295428999 cites W3101853694 @default.
- W4295428999 cites W3102426258 @default.
- W4295428999 cites W3108676144 @default.
- W4295428999 cites W3111709040 @default.
- W4295428999 cites W3126030429 @default.
- W4295428999 cites W3127981559 @default.
- W4295428999 cites W3133470123 @default.
- W4295428999 cites W3181877792 @default.
- W4295428999 cites W3197947861 @default.
- W4295428999 cites W3203975425 @default.
- W4295428999 cites W4220672333 @default.
- W4295428999 cites W4225594685 @default.
- W4295428999 cites W4280552835 @default.
- W4295428999 cites W4281633250 @default.
- W4295428999 cites W4289545188 @default.
- W4295428999 doi "https://doi.org/10.12659/msm.938365" @default.
- W4295428999 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/36093924" @default.
- W4295428999 hasPublicationYear "2022" @default.
- W4295428999 type Work @default.
- W4295428999 citedByCount "6" @default.
- W4295428999 countsByYear W42954289992023 @default.
- W4295428999 crossrefType "journal-article" @default.
- W4295428999 hasAuthorship W4295428999A5029492576 @default.
- W4295428999 hasAuthorship W4295428999A5032639696 @default.
- W4295428999 hasAuthorship W4295428999A5037581187 @default.
- W4295428999 hasAuthorship W4295428999A5087011184 @default.
- W4295428999 hasBestOaLocation W42954289992 @default.
- W4295428999 hasConcept C126322002 @default.
- W4295428999 hasConcept C134018914 @default.
- W4295428999 hasConcept C170493617 @default.
- W4295428999 hasConcept C185280430 @default.
- W4295428999 hasConcept C2776175330 @default.
- W4295428999 hasConcept C2777180221 @default.
- W4295428999 hasConcept C2777391703 @default.
- W4295428999 hasConcept C2778772119 @default.
- W4295428999 hasConcept C2778881409 @default.
- W4295428999 hasConcept C2778938600 @default.
- W4295428999 hasConcept C2779134260 @default.
- W4295428999 hasConcept C2779306644 @default.
- W4295428999 hasConcept C2780533449 @default.
- W4295428999 hasConcept C2781308992 @default.
- W4295428999 hasConcept C2910068830 @default.
- W4295428999 hasConcept C555293320 @default.
- W4295428999 hasConcept C71924100 @default.
- W4295428999 hasConceptScore W4295428999C126322002 @default.
- W4295428999 hasConceptScore W4295428999C134018914 @default.
- W4295428999 hasConceptScore W4295428999C170493617 @default.
- W4295428999 hasConceptScore W4295428999C185280430 @default.
- W4295428999 hasConceptScore W4295428999C2776175330 @default.
- W4295428999 hasConceptScore W4295428999C2777180221 @default.
- W4295428999 hasConceptScore W4295428999C2777391703 @default.
- W4295428999 hasConceptScore W4295428999C2778772119 @default.
- W4295428999 hasConceptScore W4295428999C2778881409 @default.
- W4295428999 hasConceptScore W4295428999C2778938600 @default.
- W4295428999 hasConceptScore W4295428999C2779134260 @default.
- W4295428999 hasConceptScore W4295428999C2779306644 @default.
- W4295428999 hasConceptScore W4295428999C2780533449 @default.
- W4295428999 hasConceptScore W4295428999C2781308992 @default.
- W4295428999 hasConceptScore W4295428999C2910068830 @default.
- W4295428999 hasConceptScore W4295428999C555293320 @default.
- W4295428999 hasConceptScore W4295428999C71924100 @default.
- W4295428999 hasLocation W42954289991 @default.
- W4295428999 hasLocation W42954289992 @default.
- W4295428999 hasLocation W42954289993 @default.
- W4295428999 hasOpenAccess W4295428999 @default.
- W4295428999 hasPrimaryLocation W42954289991 @default.
- W4295428999 hasRelatedWork W188703145 @default.
- W4295428999 hasRelatedWork W1969181381 @default.
- W4295428999 hasRelatedWork W2018790262 @default.
- W4295428999 hasRelatedWork W2044823377 @default.
- W4295428999 hasRelatedWork W2057332288 @default.
- W4295428999 hasRelatedWork W2058514432 @default.
- W4295428999 hasRelatedWork W2144299763 @default.
- W4295428999 hasRelatedWork W2592545469 @default.
- W4295428999 hasRelatedWork W3029979019 @default.
- W4295428999 hasRelatedWork W4295428999 @default.
- W4295428999 hasVolume "28" @default.
- W4295428999 isParatext "false" @default.
- W4295428999 isRetracted "false" @default.
- W4295428999 workType "editorial" @default.